We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$39.2B
AUM Growth
+$2.5B
Cap. Flow
+$1.83B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.25%
Holding
3,494
New
280
Increased
1,537
Reduced
1,324
Closed
255

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$118M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$117M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$108M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$66M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$65.9M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$76.5M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$63.3M
3
SYY icon
Sysco
SYY
+$59.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$53.9M
5
CAH icon
Cardinal Health
CAH
+$40.6M

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Financials 8.97%
3 Healthcare 8.75%
4 Industrials 7.19%
5 Consumer Staples 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDR
2526
DELISTED
Alder Biopharmaceuticals
ALDR
$356K ﹤0.01%
17,113
+25
+0.1% +$650
MUE
2527
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$355K ﹤0.01%
26,313
-101,514
-79% -$1.37M
MLKN icon
2528
MillerKnoll
MLKN
$1.64B
$353K ﹤0.01%
10,309
+75
+0.7% +$2.34K
RCS
2529
PIMCO Strategic Income Fund
RCS
$249M
$353K ﹤0.01%
40,212
+653
+2% +$6.03K
AIMT
2530
DELISTED
Aimmune Therapeutics
AIMT
$353K ﹤0.01%
17,260
+126
+0.7% +$2.58K
AKBA icon
2531
Akebia Therapeutics
AKBA
$234M
$352K ﹤0.01%
33,814
+5,068
+18% +$43.6K
BBRG
2532
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$352K ﹤0.01%
92,750
+29,500
+47% +$125K
WNRL
2533
DELISTED
Western Refining Logistics, LP
WNRL
$352K ﹤0.01%
+16,473
New +$357K
VICR icon
2534
Vicor
VICR
$9.63B
$351K ﹤0.01%
23,259
– –
IQNT
2535
DELISTED
Inteliquent, Inc.
IQNT
$351K ﹤0.01%
15,294
-29,022
-65% -$597K
CVE icon
2536
Cenovus Energy
CVE
$54.5B
$349K ﹤0.01%
23,091
-243
-1% -$3.66K
ITT icon
2537
ITT
ITT
$18.9B
$349K ﹤0.01%
9,057
-4,549
-33% -$171K
HTLF
2538
DELISTED
Heartland Financial USA, Inc.
HTLF
$348K ﹤0.01%
+7,243
New +$301K
LAQ
2539
DELISTED
Aberdeen Latin America Equity Fund
LAQ
$346K ﹤0.01%
+17,481
New +$362K
IPAR icon
2540
Interparfums
IPAR
$3.83B
$345K ﹤0.01%
+10,538
New +$349K
JJSF icon
2541
J&J Snack Foods
JJSF
$1.68B
$345K ﹤0.01%
2,589
-7,049
-73% -$869K
SCHH icon
2542
Schwab US REIT ETF
SCHH
$11.2B
$345K ﹤0.01%
16,816
-432,470
-96% -$8.68M
NVIV
2543
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$344K ﹤0.01%
4
– –
BHK icon
2544
BlackRock Core Bond Trust
BHK
$664M
$343K ﹤0.01%
26,381
-105,847
-80% -$1.4M
EMF
2545
Templeton Emerging Markets Fund
EMF
$324M
$343K ﹤0.01%
28,364
-2,184
-7% -$26.7K
GUNR icon
2546
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.09B
$343K ﹤0.01%
+11,974
New +$335K
SNBR
2547
DELISTED
Sleep Number
SNBR
$343K ﹤0.01%
15,154
+69
+0.5% +$1.49K
SSYS icon
2548
Stratasys
SSYS
$769M
$342K ﹤0.01%
20,665
-1,510
-7% -$29.6K
CTR
2549
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$341K ﹤0.01%
5,343
+266
+5% +$16.6K
ARI
2550
Apollo Commercial Real Estate
ARI
$871M
$340K ﹤0.01%
20,469
-8,527
-29% -$143K
100 101
102
103 104

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Raymond James & Associates held 3,494 positions worth $39.2B, up 6.8% from $36.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $1.83B of net new capital in Q4 2016, opening 280 new positions and adding to 1,537 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $76.5M trimmed.

  • Raymond James & Associates's largest Q4 2016 buy was Invesco S&P 500 High Beta ETF: 442,572 shares worth $16.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2016, an estimated $118M increase.
  • Raymond James & Associates's biggest Q4 2016 reduction was Reynolds American Inc, cutting an estimated $76.5M.
  • Raymond James & Associates fully exited Amsurg Corp in Q4 2016, selling an estimated $29.2M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $39.2B portfolio in Q4 2016.
  • Raymond James & Associates opened 280 new positions and closed 255 in Q4 2016.
  • Raymond James & Associates's portfolio value rose 6.8% quarter-over-quarter to $39.2B.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.